U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
NEW YORK, May 02, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of New York on behalf of investors who purchased Desarrolladora Homex, S.A.B. de C.V. a/k/a/ Homex Development Corp. (OTC:DHHXF) (formerly (NYSE:HXM); formerly (OTCMKTS:DHOXQ); formerly (OTCMKTS:DHOXY)) securities between April 30, 2012 through May 5, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/desarrolladora-homex?wire=3. There is no cost or obligation to you.
According to the complaint, during the class period the Company made false and/or misleading statements and/or failed to disclose that: (1) between 2010 and 2013, Homex overstated its revenue by 355% or roughly $3.3 billion by reporting fictitious sales of more than 100,000 homes; (2) between 2010 and 2013, Homex overstated the number of units it sold by over 100,000 units or 317% of actual units sold; (3) Homex and certain of its Headquarters Financial Reporting Personnel knowingly and intentionally engaged in a scheme to materially overstate Homex’s revenues, homes sold, and other related financial items; and (4) as a result, defendants’ statements about Homex’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Homex you have until May 15, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/desarrolladora-homex?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
